The use of recombinant human erythropoietin in hemoglobinopathy and uremia

Dialysis and Transplantation

Volumn 30, Issue 6, 2001, Pages 368-372

  Di Iorio, B R ^a   Aucella, F ^a   Stallone, C ^a   Aversano, A ^a   Rubino, R ^a   Bellizzi, V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; CHRONIC DISEASE; CONTROLLED STUDY; DIALYSIS; HEMOGLOBINOPATHY; HUMAN; HYPERPARATHYROIDISM; INFECTION; INFLAMMATION; IRON DEFICIENCY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SEPSIS; SICKLE CELL ANEMIA; THALASSEMIA MINOR; TREATMENT INDICATION; UREMIA;

EID: 0034989370     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Anemia of end-stage renal disease
2. rhEPO hyporesponsiveness: Who and why?
3. rhEPO hyporesponsiveness: Who and why?
4. Hyporesponsiveness to recombinant human erythropoietin in dialysis patients
5. European Best Practice Guidelines 14-16: Inadequate response to Epoetin
6. Survey of hemodialysis patients with thalassaemia minor: Haematological parameters and the use of rhEPO
7. Should anaemia in subtypes of CRF patients be managed differently?
8. Determinants of haemoglobin level in steady-state homozygous sickle cell disease
9. Pain in sickle cell disease. Rates and risk factors
10. Erythropoietin and renal function in sickle cell disease
11. Administration of erythropoietin to patients with β-thalassaemia intermedia: A preliminary trial
12. Trial of erythropoietin: 3 patients with thalassaemia intermedia
13. Administration of high doses of rhEPO to patients with beta-thalassemia intermedia: A preliminary trial
14. Resistance to EPO in hemodialysis patients with heterozygous hemoglobinopathy J-Meinung
15. NFK-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
16. Canadian clinical practice guidelines for the management of anemia coexistent with CRF
17. European best practice guidelines for the management of anemia in patients with CRF
18. Erythropoietin dose requirement in patients with HbH disease and renal failure
19. Beneficial effect of erythropoietin in b thalassaemia patients on dialysis
20. Use of erythropoietin in thalassaemic patients
21. Influence of thalassaemia on the response to erythropoietin in dialysis patients
22. Erythropoietin dose requirement in a patient with β-thalassaemia and CRF
23. Recombinant human erythropoietin for anaemia in thalassaemia minor patients on dialysis
24. Erythropoietin for anaemia of ESRD in beta-thalassaemia trait
25. Resistance to recombinant human erythropoietin treatment in thalassaemic patients on chronic hemodialysis: A real clinical entity
26. The use of rhEPO in hemodialyzed patients with thalassaemia minor
27. The role of erythropoietin in the treatment of thalassaemia